✦ LIBER ✦

1–37 Multicenter Randomized Phase III Trial of Epirubicin Plus Paclitaxel vs Epirubicin Followed by Paclitaxel in Metastatic Breast Cancer Patients: Focus on Cardiac Safety

✍ Scribed by Seidman, A.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter randomized phase III trial o

✍ Baldini, E; Prochilo, T; Salvadori, B; Bolognesi, A; Aldrighetti, D; Venturini, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Capecitabine plus paclitaxel versus epir

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

P.39 Docetaxel plus epirubicin (DE) vs d

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB